1. Pulmonary Embolism (PE)

Pulmonary embolism occurs when a blood clot blocks an artery in the lungs, leading to reduced oxygenation and potentially life-threatening complications.

Urokinase dissolves the obstructing clot, helping to:

▸ Restore blood flow through the lungs

▸ Reduce the risk of respiratory failure

▸ Lower mortality rates

Its fast clot-breaking action makes it an important option for critical PE cases.

2. Deep Vein Thrombosis (DVT)

Clots in deep veins, usually in the legs, are a symptom of DVT. These clots could lead to:

▸ Pain

▸ Swelling

▸ Danger of rupturing and resulting in a pulmonary embolism

By aiding in the clot's dissolution, urokinase reduces discomfort and averts potentially harmful consequences.

3. Acute Myocardial Infarction (Heart Attack)

Heart attacks often occur when a clot blocks a coronary artery. While tissue plasminogen activator (tPA) is more commonly used, urokinase remains a valuable alternative in certain clinical scenarios. It:

▸ Breaks down the clot blocking the coronary artery

▸ Reduces damage to heart muscle

▸ Improves patient outcomes

4. Peripheral Artery Occlusion

Blockages in the arteries supplying the limbs are the cause of this disorder, which increases the risk of tissue damage, discomfort, and ischemia.

Arterial clots are cleared by urokinase, which aids in:

▸ Restore blood flow

▸ Reduce ischemia

▸ Stop the loss of tissue

▸ Maintain limb functionality

Urokinase is a dependable intervention, and prompt therapy is crucial.

5. Catheter-Associated Thrombosis

Blood clots have the potential to obstruct central venous catheters.

Direct administration of urokinase into the catheter can be used to:

▸ Break apart the clot

▸ Restore the patency of the catheter

▸ Keep the equipment operating properly

6. Occluded Arteriovenous Fistulas or Grafts in Dialysis Patients

Clots can block AV fistulas or grafts in hemodialysis patients.

Urokinase helps:

▸ Clear the obstruction

▸ Ensure consistent access to dialysis

▸ Prevent treatment disruptions